Assessment of Circuit Rebreathing During CPAP Therapy
Launched by BRIGHAM AND WOMEN'S HOSPITAL · Jul 10, 2025
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at how different designs of CPAP masks affect the way air flows and how much exhaled carbon dioxide (CO₂) might be breathed back in during sleep for people with obstructive sleep apnea (OSA). OSA is a condition where breathing stops and starts during sleep, and CPAP machines help keep the airway open by providing steady air pressure through a mask. The researchers want to understand which mask designs work best to keep the air fresh and safe throughout the night.
People who might join this study are adults aged 21 to 70 who have moderate to severe OSA and have used a CPAP machine before. Participants should have a body weight within a healthy to moderately high range (BMI between 18 and 40) and not have other serious health problems like severe lung or heart disease. If you join, you can expect to try different CPAP masks while researchers check how air flows and how much CO₂ is rebreathed during sleep. This study is currently looking for volunteers, and your participation can help improve CPAP mask designs for better comfort and safety in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Moderate to severe OSA (AHI\>20)
- • Self-reported CPAP users or have previously used CPAP
- • Self-reported holding pressure of maximum 13 cmH2O (if known)
- • Age: 21-70
- • BMI: 18-40 kg/m2
- Exclusion Criteria:
- • Self-reported severe mouth-breathing
- • Requirement for nocturnal supplemental oxygen or other ventilatory support
- • Severe cardiovascular or pulmonary disease
- • Any unstable or acute medical condition
- • Any additional sleep disorder, including insomnia, except for OSA.
About Brigham And Women's Hospital
Brigham and Women's Hospital (BWH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As an integral part of the Partners HealthCare system, BWH combines cutting-edge medical education with a focus on patient-centered care, fostering an environment that promotes groundbreaking clinical trials across various specialties. The hospital is dedicated to translating scientific discoveries into effective treatments, making significant contributions to the fields of cardiovascular medicine, oncology, and women's health, among others. With a robust infrastructure for research and a collaborative approach, BWH aims to improve patient outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Atqiya Aishah, PhD
Principal Investigator
Harvard Medical School & Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported